Julia H Arnsten MD
Addiction Medicine, Healthcare Research and Healthcare Policy
Professor, Medicine, A Einstein College of Medicine of Yeshiva Univ
Join to View Full Profile
3300 Kossuth AveBronx, NY 10467
Phone+1 718-920-6641
Dr. Arnsten is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 1990 - 1993- New York University School of MedicineClass of 1990
Mass General Brigham/Massachusetts General HospitalFellowship, Addiction Medicine
Certifications & Licensure
FL State Medical License 2023 - 2027
NY State Medical License 1991 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Preventive Medicine Addiction Medicine
Clinical Trials
- Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users Start of enrollment: 2009 Dec 01
- Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment Start of enrollment: 2012 Jun 01
- Neurocognitive Effects of Opiate Agonist Treatment Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO study.Irene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, Abigail W Batchelder, Megan Groome
Journal of Psychosomatic Research. 2025-10-17 - 1 citationsDeveloping Medical Cannabis Competencies: A Consensus Statement.Yuval Zolotov, Leslie Mendoza Temple, Richard Isralowitz, David A Gorelick, Rebecca Abraham
JAMA Network Open. 2025-10-01 - Design of a randomized tobacco cessation trial among FDNY World Trade Center responders in a lung cancer screening program.David G Goldfarb, Tyrone Moline, David J Prezant, Matthew P Bars, Rachel Zeig-Owens
Addiction Science & Clinical Practice. 2025-08-05
Press Mentions
CQ Future: TelehealthJuly 17th, 2020- Managing Hypertension in Rural Uganda: Realities and Strategies 10 Years of Experience at a District Hospital Chronic Disease ClinicJune 5th, 2020
CBD Marketers Should Brace for FTC Enforcement Action This Year: OfficialFebruary 28th, 2020- Join now to see all
Grant Support
- Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)ALBERT EINSTEIN COLLEGE OF MEDICINE2021–2026
- HIV And Substance Abuse Clinical Addiction Research And Education (CARE) ProgramNational Institute On Drug Abuse2011–2012
- Neurocognitive Effects Of Buprenorphine Among HIV+ Opioid UsersNational Institute On Drug Abuse2009–2011
- Clinical Addiction Research And Education ProgramNational Institute On Drug Abuse2007–2010
- Efficacy And COST Of Haart DOT In Methadone ClinicsNational Institute On Drug Abuse2004–2007
- Clinical Addiction Research And Education (CARE) ProgramNational Institute On Drug Abuse2002–2005
- Efficacy And COST Of Haart DOT In Methadone ClinicsNational Institute On Drug Abuse2003
- HIV Therapy Adherence And Viral Resistance In Drug UsersNational Institute On Drug Abuse1999–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
